AmpliTech Group (NASDAQ: AMPG) reported Q3 2026 revenue of $6.58 million, up 8% year-over-year but less than half the $14 million consensus estimate. The miss was not a demand problem. It was a timing problem, and the company's revised full-year outlook of at least $28 million (down from the $50 million target withdrawn in August) makes that explicit. Whether the backlog converts fast enough to justify the investment spend is what matters now.
The headline numbers capture a company mid-transition. Revenue grew modestly from $6.09 million a year ago, but the composition shifted. Spectrum Semiconductor Materials distribution revenue jumped 36.4% to $2.89 million, while the manufacturing and engineering segment slipped to $3.70 million from $3.98 million. Gross margin expanded sequentially to 34.2% from 27.9% in Q2, and nine-month gross profit rose 41.1% to $7.07 million. The net loss narrowed sequentially to $1.89 million ($0.07 per share) from $3.09 million in Q2. But the nine-month loss widened to $6.50 million from $3.80 million a year ago, reflecting higher SG&A ($3.38 million vs. $2.48 million) and R&D ($0.86 million vs. $0.70 million).

The EPS miss of $0.07 against a $0.12 estimate is less concerning than the revenue gap. AmpliTech is spending ahead of revenue, building production infrastructure and engineering capacity for 5G and O-RAN programs that have not yet shipped in volume. Management acknowledged that "certain investments in engineering, manufacturing readiness, and supply chain capabilities are being made in advance of the related anticipated customer orders and deliveries." That is a deliberate strategy. It also leaves the P&L exposed if revenue recognition slips further.
The real story this quarter is the gap between bookings and revenue. AmpliTech announced a record backlog exceeding $52 million as of October, including a $21.7 million follow-on O-RAN order from an Asian operator and a $1.03 million LNA order from a Fortune 1000 SATCOM customer. October bookings alone were near $25 million. Q3 revenue was $6.58 million. The company attributed the shortfall to "supply-chain constraints and customer-directed deployment delays, particularly among certain international 5G network operators." The original $50 million target was based on customer-provided shipment forecasts that "subsequently shifted beyond their anticipated delivery periods."
This creates a credibility issue. Management withdrew the $50 million target in August, but the Q3 print shows how far actual revenue lagged even a reduced trajectory. The revised $28 million full-year guidance implies Q4 revenue of roughly $8 million. Plausible given the backlog, but still well below the run-rate implied by the order book.
The balance sheet provides a cushion. AmpliTech holds $30.27 million in cash and marketable securities, working capital of $42.14 million, and shareholders' equity that doubled to $65.7 million, largely from the July Series A rights exercise that raised $20.11 million. Per management, the company can fund operations for at least 18 months.
The strategic milestones are real. Approved vendor status with a major telecom infrastructure provider. A completed dedicated production line. Demonstrated interoperability with OCUDU. These are necessary steps for scaling. They do not guarantee revenue acceleration. The risk is that customer deployment delays become structural rather than episodic, particularly for international 5G operators facing permitting, licensing, and geopolitical hurdles.
Backlog is not revenue. AmpliTech's record order book and strong balance sheet give it time, but the clock is ticking on converting those orders into cash. The $28 million full-year guide is a floor, not a ceiling. If Q4 revenue comes in closer to $10 million, the trajectory improves. If it lands at $8 million, the market will start asking whether 2027 guidance will also disappoint. The next quarter's revenue recognition will matter more than the backlog number.
The company has the orders. Now it needs to ship them.
